Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced participation in the following September investor conferences.
Citi 18th Annual BioPharma Conference Members of senior management will meet with investors on Wednesday, September 6, 2023.
H.C. Wainwright 25th Annual Global Investment Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer will provide a company update on Tuesday, September 12, 2023, at 2:00 pm Eastern Time.
Baird 2023 Global Healthcare Conference Dr. Coulie will participate in a fireside chat on Wednesday, September 13, 2023. This is an invitation-only event hosted by Baird.
Cantor Global Healthcare Conference Dr. Coulie and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Thursday, September 28, 2023 at 11:30 am Eastern Time.
Interested parties may access the live webcasts of the H.C. Wainwright presentation and the Cantor fireside chat by visiting the Investor Relations’ Events & Presentation page of Pliant’s website. The webcast replays will be archived on the Pliant website for 30 days following the conclusion of the events.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.